THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Gilead expands voluntary licensing agreements for investigational once-yearly lenacapavir
WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
Gilead expanded six royalty-free voluntary licensing agreements covering 120 high-incidence countries to support manufacturing readiness, technology transfer and future supply planning for investigational once-yearly lenacapavir.
- Current status
- Official collaboration
- Known availability
- The published source describes the collaboration; timing details remain under review.
- Place
- International, International
- Source checked
- September 23, 2026
FOLLOW THE STORY